Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, whereas the influenza A virus (IAV) causes seasonal epidemics and occasional pandemics. Both viruses lead to widespread infection and death. SARS-CoV-2 and the influenza virus are RNA viruses. The SARS-CoV-2 genome is an approximately 30 kb, positive sense, 5′ capped single-stranded RNA molecule. The influenza A virus genome possesses eight single-stranded negative-sense segments. The RNA secondary structure in the untranslated and coding regions is crucial in the viral replication cycle. The secondary structure within the RNA of SARS-CoV-2 and the influenza virus has been intensively studied. Because the whole of the SARS-CoV-2 and influenza virus replication cycles are dependent on RNA with no DNA intermediate, the RNA is a natural and promising target for the development of inhibitors. There are a lot of RNA-targeting strategies for regulating pathogenic RNA, such as small interfering RNA for RNA interference, antisense oligonucleotides, catalytic nucleic acids, and small molecules. In this review, we summarized the knowledge about the inhibition of SARS-CoV-2 and influenza A virus propagation by targeting their RNA secondary structure.
Топ-30
Журналы
|
1
|
|
|
Journal of Biomolecular Structure and Dynamics
1 публикация, 5.56%
|
|
|
Chemistry Africa
1 публикация, 5.56%
|
|
|
International Journal of Molecular Sciences
1 публикация, 5.56%
|
|
|
Computational and Structural Biotechnology Journal
1 публикация, 5.56%
|
|
|
Biomolecules
1 публикация, 5.56%
|
|
|
Intelligent Pharmacy
1 публикация, 5.56%
|
|
|
Advanced Biotechnology
1 публикация, 5.56%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 публикация, 5.56%
|
|
|
Water Science and Technology
1 публикация, 5.56%
|
|
|
Antiviral Research
1 публикация, 5.56%
|
|
|
Russian Chemical Reviews
1 публикация, 5.56%
|
|
|
Journal of Molecular Liquids
1 публикация, 5.56%
|
|
|
Scientific data
1 публикация, 5.56%
|
|
|
RNA Biology
1 публикация, 5.56%
|
|
|
Discover Chemistry
1 публикация, 5.56%
|
|
|
Scientific Reports
1 публикация, 5.56%
|
|
|
Molecular Therapy - Nucleic Acids
1 публикация, 5.56%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 публикация, 5.56%
|
|
|
1
|
Издатели
|
1
2
3
4
5
|
|
|
Springer Nature
5 публикаций, 27.78%
|
|
|
Elsevier
5 публикаций, 27.78%
|
|
|
Taylor & Francis
2 публикации, 11.11%
|
|
|
MDPI
2 публикации, 11.11%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 5.56%
|
|
|
IWA Publishing
1 публикация, 5.56%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 5.56%
|
|
|
Frontiers Media S.A.
1 публикация, 5.56%
|
|
|
1
2
3
4
5
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.